Literature DB >> 12067709

Protein kinase A balances the growth factor-induced Ras/ERK signaling.

Juha-Pekka Pursiheimo1, Anni Kieksi, Markku Jalkanen, Markku Salmivirta.   

Abstract

Protein kinase A (PKA) has been proposed to regulate the signal transduction through the Ras/extracellular-regulated kinase (ERK) pathway. Here we demonstrate that when the PKA activity was inhibited prior to growth factor stimulus the signal flow through the Ras/ERK pathway was significantly increased. Furthermore, the data indicated that this PKA-mediated regulation was simultaneously targeted to the upstream kinase Raf-1 and to the ERK-specific phosphatase mitogen-activated protein kinase phosphatase-1 (MKP-1). Moreover, our data suggested that the level of PKA activity determined the transcription rate of mkp-1 gene, whereas the Ras/ERK signal was required to protect the MKP-1 protein against degradation. These results point to a tight regulatory relationship between PKA and the growth factor signaling, and further suggest an important role for basal PKA activity in such regulation. We propose that PKA adjusts the activity of the Ras/ERK pathway and maintains it within a physiologically appropriate level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067709     DOI: 10.1016/s0014-5793(02)02864-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  FK506 potentiates NGF-induced neurite outgrowth via the Ras/Raf/MAP kinase pathway.

Authors:  Raymond D Price; Takayuki Yamaji; Nobuya Matsuoka
Journal:  Br J Pharmacol       Date:  2003-10-14       Impact factor: 8.739

Review 2.  Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?

Authors:  Hildegard M Schuller
Journal:  Nat Rev Cancer       Date:  2009-02-05       Impact factor: 60.716

3.  PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.

Authors:  Edita Aksamitiene; Boris N Kholodenko; Walter Kolch; Jan B Hoek; Anatoly Kiyatkin
Journal:  Cell Signal       Date:  2010-05-12       Impact factor: 4.315

4.  Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1.

Authors:  Steven K Huang; Scott H Wettlaufer; Jooho Chung; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2008-04-17       Impact factor: 6.914

5.  Transcriptomic analysis of cyclic AMP response in bovine cumulus cells.

Authors:  D R Khan; C Guillemette; M A Sirard; F J Richard
Journal:  Physiol Genomics       Date:  2015-06-16       Impact factor: 3.107

6.  Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth.

Authors:  Héctor R Quintá; Darío Maschi; Celso Gomez-Sanchez; Graciela Piwien-Pilipuk; Mario D Galigniana
Journal:  J Neurochem       Date:  2010-09-28       Impact factor: 5.372

7.  Combinatorial roles of protein kinase A, Ets2, and 3',5'-cyclic-adenosine monophosphate response element-binding protein-binding protein/p300 in the transcriptional control of interferon-tau expression in a trophoblast cell line.

Authors:  Padmalaya Das; Toshihiko Ezashi; Rangan Gupta; R Michael Roberts
Journal:  Mol Endocrinol       Date:  2007-11-01

8.  The putative tumor suppressor VILIP-1 counteracts epidermal growth factor-induced epidermal-mesenchymal transition in squamous carcinoma cells.

Authors:  Katharina Schönrath; Andres J Klein-Szanto; Karl H Braunewell
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

9.  Prostaglandin E2 reverses curcumin-induced inhibition of survival signal pathways in human colorectal carcinoma (HCT-15) cell lines.

Authors:  Adeeb Shehzad; Salman Ul Islam; Jaetae Lee; Young Sup Lee
Journal:  Mol Cells       Date:  2014-11-26       Impact factor: 5.034

Review 10.  The Oncogenic Functions of Nicotinic Acetylcholine Receptors.

Authors:  Yue Zhao
Journal:  J Oncol       Date:  2016-02-14       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.